FEC Greenlights Nat’l Snakebite Centre Amid N73.9bn Health Funding

0
ABUJA – With over 43,000 Nigerians affected by snakebites annually, the Federal Executive Council (FEC) took a resolution on Monday, to establish a National Snakebite Treatment and Research Centre.
In addition to the centre, FEC approved other health sector interventions valued at approximately N73.9 billion.
Briefing reporters on some of the resolutions reached, the Coordinating Minister of Health and Social Welfare, Professor Muhammad Ali Pate, described the interventions as part of efforts to strengthen healthcare delivery and expand access to essential medical services across Nigeria.
He noted that the country records an estimated 43,000 snakebite cases annually, many of which result in deaths, disabilities, and severe socioeconomic consequences, particularly in the North-East, North- West, and North-Central regions, where the burden is greatest.
Giving more details on the approvals, Pate said, “The new centre will provide specialised treatment, conduct research on snakebite prevention and management, ensure sustainable access to quality antivenom, and partner with international institutions.”
He went on to state that N6.9 billion was approved for the procurement of 10 compressed natural gas CNG-powered blood donation mobile clinics for the National Blood Service Agency to improve blood donation, collection and distribution nationwide.
The Council further approved N62 billion for the procurement of tuberculosis TB commodities to strengthen Nigeria’s response to one of the world’s highest TB burdens, while reducing dependence on foreign donors and supporting future local production of TB medicines.
The minister added that N5 billion was also approved for the procurement of reproductive health and family planning commodities through the National Primary Health Care Development Agency to boost maternal health services and expand access to voluntary family planning nationwide.
“These approvals underscore the Tinubu administration’s commitment to strengthening health infrastructure, expanding access to essential medicines and promoting local pharmaceutical manufacturing,” Pate stated.





